I recognize that it has been targeted as a point of interest, primarily through the media. I'd have to say that where pharmaceutical manufacturers are concentrated outside of this region, it hasn't been an area that I have personally focused on. I think my colleagues in the national office have looked at this.
I know that Jayson Myers, when he spoke to the committee, looked at the very base number of 80,000 jobs in general across the country, without allowing for growth, getting back to your earlier question about the possibilities the agreement will offer.
But on pharmaceuticals, I'm sorry, I can't offer any specifics.